3-IN-PP1
3-IN-PP1 is a protein kinase D (PKD) inhibitor. 3-IN-PP1 has potent pan-PKD inhibitory activity for PKD1, PKD2 and PKD3 with IC50 values of 108, 94 and 108 nM, respectively. 3-IN-PP1 also is a broad spectrum anticancer agent and has inhibition of several tumor cells growth. 3-IN-PP1 can be used for the research of cancer[1].
Product Specifications
CAS Number
2227110-54-3
UNSPSC
12352005
Target
PKD
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/3-in-pp1.html
Purity
99.37
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
NC1=C2C(N(C(C)(C)C)N=C2C3=CNC4=C3C=CC=C4)=NC=N1
Molecular Formula
C17H18N6
Molecular Weight
306.37
References & Citations
[1]Philippe Gilles, et al. Design, synthesis and biological evaluation of pyrazolo[3,4-d]pyrimidine-based protein kinase D inhibitors. Eur J Med Chem
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PKD1; PKD2; PKD3
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Cytokeratin, Acidic (Type I or LMW) (Epithelial Marker) (KRTL/1577R), CF594 conjugate, 0.1mg/mL
3-(Ethoxycarbonyl)-1-(2,3,5-tri-O-acetyl-Beta-D-ribofuranosyl)-pyridinium-d4 Triflate
![KMT6/EZH2 Recombinant Rabbit Monoclonal Antibody [PSH04-14]](https://cdn.genprice.uk/products/992/68dd1c8a061270361ea81222/imageurl/ha722095.webp)
KMT6/EZH2 Recombinant Rabbit Monoclonal Antibody [PSH04-14]
![2-[2-[2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethoxy]ethoxy]ethanol](https://cdn.genprice.uk/products/572/2710550556511/imageurl/trc-d418685-50mg.webp)